In Other News

• Blood Plasma Biomarker Discovered in Hospitalized COVID-19 Patients May Predict ARDS Severity

• Portable Nasal Spray That Destroys SARS-CoV-2 Could Prove to Be Breakthrough COVID-19 Treatment

• Landmark Discovery of Critical SARS-CoV-2 Enzyme in First Ever X-Ray Images Could Improve Design of New COVID-19 Drugs

• Advantech Launches One-to-One Thermal Screening Kiosk with Video AI-Integrated System to Reduce Spread of COVID-19

• Widely Used Transplant-Rejection Drug Cyclosporine Identified as Potential New COVID-19 Treatment

• Massive X-Ray Screening Identifies Promising Candidates for Drugs Against COVID-19

• AI-Based Approach Could Help Develop New Protein-Based COVID-19 Antibody Therapies

• New-Baseline Chest Imaging in Discharged COVID-19 Patients Could Help Identify Those at Highest Risk of Reinfection

• AI-Accelerated Method Monitors COVID-19 Disease Severity Over Time from Patient Chest CT Scans

• Discovery of Cancer Drug That Lessens Toxicity of SARS-COV-2 Proteins Opens Door to Testing More Effective COVID-19 Drugs

• COVID-19 Test Uses Novel High-Throughput Molecular Method for Detecting SARS-CoV-2 Infection in Saliva Samples

• New COVID-19 Diagnostic Test Detects SARS-CoV-2 Virus Even When It Mutates

• COVID-19 Group Testing Method Delivers Results 13 Times Faster than Individual Testing of Each Sample

• X-Rays Combined with AI Offer Fast Diagnostic Tool in Detecting COVID-19

• Novel 15-Minute Microfluidic DLD Assay Could Assess Severity of Immune Response to COVID-19 Infection

• New Mass Spectrometry-Based Technique Enables Ultrafast Identification of COVID-19 Biomarkers

• Evidence of SARS-CoV-2 Infecting Mouth’s Cells Further Confirms Reliability of Saliva Testing for Diagnosing COVID-19

• AACC Issues Updated Recommendations on Uses and Limitations of COVID-19 Antibody Tests

• Rapid Antigen Tests Better at Correctly Identifying COVID-19 in People with Symptoms than in People Without Symptoms

• Powerful Brain Imaging Allows Researchers to Pinpoint Tissue Damage Following COVID-19 Illness

• Commonly Used Antiviral and Anti-Malarial Drugs Found to Work Similarly to Gilead’s Remdesivir in Preventing SARS-CoV-2 Replication

• Beckman Coulter's SARS-CoV-2 IgG II Antibody Test Receives FDA Emergency Use Authorization

• First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay Receives FDA EUA